These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35358645)

  • 1. Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing.
    Yenduri G; Costa AP; Xu X; Burgess DJ
    Int J Pharm; 2022 May; 619():121700. PubMed ID: 35358645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural networks in tandem with molecular descriptors as predictive tools for continuous liposome manufacturing.
    Sansare S; Duran T; Mohammadiarani H; Goyal M; Yenduri G; Costa A; Xu X; O'Connor T; Burgess D; Chaudhuri B
    Int J Pharm; 2021 Jun; 603():120713. PubMed ID: 34019974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design Approach in Liposomal Formulations: Robust Product Development.
    Alshaer W; Nsairat H; Lafi Z; Hourani OM; Al-Kadash A; Esawi E; Alkilany AM
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical process parameters in manufacturing of liposomal formulations of amphotericin B.
    Rivnay B; Wakim J; Avery K; Petrochenko P; Myung JH; Kozak D; Yoon S; Landrau N; Nivorozhkin A
    Int J Pharm; 2019 Jun; 565():447-457. PubMed ID: 31071418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid scale-up and production of active-loaded PEGylated liposomes.
    Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
    Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing API raw material variability in a continuous manufacturing line - Prediction of process robustness.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Vervaet C; De Beer T
    Int J Pharm; 2019 Oct; 569():118525. PubMed ID: 31319146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous processing of paclitaxel polymeric micelles.
    Gupta A; Costa AP; Xu X; Burgess DJ
    Int J Pharm; 2021 Sep; 607():120946. PubMed ID: 34333023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation.
    Van Haute D; Jiang W; Mudalige T
    Int J Pharm; 2019 Oct; 569():118603. PubMed ID: 31401296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Drug Loaded Liposomal Formulations by a Novel Stirred Cell Ultrafiltration Technique.
    Soni PK; Saini TR
    Pharm Nanotechnol; 2021; 9(5):347-360. PubMed ID: 34819014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method.
    Merlo-Mas J; Tomsen-Melero J; Corchero JL; González-Mira E; Font A; Pedersen JN; García-Aranda N; Cristóbal-Lecina E; Alcaina-Hernando M; Mendoza R; Garcia-Fruitós E; Lizarraga T; Resch S; Schimpel C; Falk A; Pulido D; Royo M; Schwartz S; Abasolo I; Pedersen JS; Danino D; Soldevila A; Veciana J; Sala S; Ventosa N; Córdoba A
    J Supercrit Fluids; 2021 Jul; 173():105204. PubMed ID: 34219919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.
    Ballacchino G; Weaver E; Mathew E; Dorati R; Genta I; Conti B; Lamprou DA
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalable microfluidic method for tunable liposomal production by a design of experiment approach.
    Buttitta G; Bonacorsi S; Barbarito C; Moliterno M; Pompei S; Saito G; Oddone I; Verdone G; Secci D; Raimondi S
    Int J Pharm; 2024 Jul; ():124460. PubMed ID: 39004291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of a new processing approach for manufacturing topical liposomes-in-hydrogel drug formulations by dual asymmetric centrifugation.
    Ingebrigtsen SG; Škalko-Basnet N; Holsæter AM
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1375-83. PubMed ID: 26710826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration.
    Barros C; Aranha N; Severino P; Souto EB; Zielińska A; Lopes A; Rios A; Batain F; Crescencio K; Chaud M; Alves T
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34068793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles.
    Silva J; Mendes M; Cova T; Sousa J; Pais A; Vitorino C
    AAPS PharmSciTech; 2018 Jul; 19(5):2383-2394. PubMed ID: 29869314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
    Fan Y; Marioli M; Zhang K
    J Pharm Biomed Anal; 2021 Jan; 192():113642. PubMed ID: 33011580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.